Finance

Lists
ABTT34:BVMF
Abbott Laboratories BDR
41,25 R$
-1,50%
(-0,63) 1D
6 қаз., 11:33:41 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for ABTT34...
Open
41,66 R$
High
41,66 R$
Low
41,25 R$
Mkt. cap
166,88 млрд
Avg. vol.
260,00
Volume
270,00
52-wk high
60,34 R$
52-wk low
33,34 R$
Shares outstanding
1,73 млрд
No. of employees
115 м.
Open
41,66 R$
High
41,66 R$
Low
41,25 R$
Mkt. cap
166,88 млрд
Avg. vol.
260,00
Volume
270,00
52-wk high
60,34 R$
52-wk low
33,34 R$
Shares outstanding
1,73 млрд
No. of employees
115 м.
News stories
From web sources and news partners
Profile
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices. Abbott operates in over 160 countries and sources from at least 62 suppliers worldwide. Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. The company is ranked 107th on the Fortune 500 and 144th on the Forbes Global 2000. Wikipedia
About Abbott Laboratories BDR
CEORobert B. Ford
Employees115 м.
Founded1888
HeadquartersЧикаго, Иллинойс, Америка Құрама Штаттары
SectorMedical device
Websiteabbott.com
Last report
2026 ж. 16 шіл.
Fiscal period
Q2 2026
EPS / Est. (USD)
1,31 $ / 1,28 $
+2,61%beat
Revenue / Est. (USD)
12,59 млрд / 12,52 млрд
+0,61%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
11,37 млрд
11,46 млрд
11,16 млрд
12,59 млрд
Cost of goods sold
5,08 млрд
4,91 млрд
4,89 млрд
5,32 млрд
Cost of revenue
5,08 млрд
4,91 млрд
4,89 млрд
5,32 млрд
Research and development expenses
766,00 млн
720,00 млн
767,00 млн
892,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,90 млрд
2,93 млрд
3,58 млрд
3,87 млрд
Operating expense
4,09 млрд
4,07 млрд
4,77 млрд
5,42 млрд
Total operating expenses
9,16 млрд
8,98 млрд
9,66 млрд
10,74 млрд
Operating income
2,20 млрд
2,48 млрд
1,50 млрд
1,85 млрд
Other non operating income
2,00 млн
-15,00 млн
-
-25,00 млн
EBT including unusual items
2,18 млрд
2,36 млрд
1,45 млрд
1,52 млрд
EBT excluding unusual items
2,18 млрд
2,44 млрд
1,45 млрд
1,52 млрд
Income tax expense
536,00 млн
582,00 млн
372,00 млн
596,00 млн
Effective tax rate
24,59%
24,68%
25,67%
39,11%
Other operating expenses
-
-
-
-
Net income
1,64 млрд
1,78 млрд
1,08 млрд
928,00 млн
Net profit margin
14,46%
15,50%
9,65%
7,37%
Earnings per share
1,30
1,50
1,15
1,31
Interest and investment income
77,00 млн
78,00 млн
106,00 млн
52,00 млн
Interest expense
-121,00 млн
-120,00 млн
-174,00 млн
-351,00 млн
Net interest expenses
-44,00 млн
-42,00 млн
-68,00 млн
-299,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
3,00 млрд
3,27 млрд
2,31 млрд
2,91 млрд
Gain or loss from assets sale
-
65,00 млн
-
-
AI content may include mistakes. Learn more
Google қолданбалары